Abstract
In small-cell lung carcinoma (SCLC) tumour cell contamination of leukaphereses is unknown. The present study was performed to define appropriate markers for reverse transcriptase polymerase chain reaction (RT-PCR), then to assess the contamination rate of leukaphereses and corresponding bone marrow samples. Immunocytochemistry (ICC) and RT-PCR methods were also compared. Among the 33 patients included, analyses were performed in 16 who had multiple leukaphereses and 17 who had only bone marrow. Leukapheresis products and bone marrow were analysed by ICC using several specific monoclonal antibodies against neural-cell adhesion molecule (N-CAM), epithelial glycoprotein (EGP-40) and cytokeratins (CK). Samples were also analyzed by RT-PCR for expression for N-CAM, synaptophysin, neuron-specific enolase, chromogranin, cytokeratin-18/-19, CEA, EGP-40, apomucin type 1 (MUC-1) and human endothelial cell-specific molecule (ESM-1). Using ICC staining, contaminating tumour cells were detected in 34% of leukaphereses (27% in patients with limited disease and 43% in those with extensive disease). N-CAM was the most reliable marker for detection of contamination. For RT-PCR, CK-19 and CEA were the only appropriate markers. Positive signal rate in leukaphereses increased to 78% (89% for patients with limited disease and 67% for extensive disease). In bone marrow, both techniques were in agreement whereas in leukaphereses, RT-PCR was better than ICC. A high rate of tumour cell contamination was demonstrated not only in bone marrow but also in leukaphereses from SCLC patients. The most appropriate technique was RT-PCR mainly in patients with limited disease. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arriagada R, Le Chevalier T, Pignon JP, Riviere A, Monnet I, Chomy P, Tuchais C, Tarayre M and Ruffie P (1993) Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 329: 1848–1852
Beiske K, Myklebust AT, Aamdal S, Langholm R, Jakobsen E and Fodstad O (1992) Detection of bone marrow metastases in small cell lung cancer patients. Comparison of immunologic and morphologic methods. Am J Pathol 141: 531–538
Benhattar J, Perey L, Peters R and Leyvraz S (1998) Reverse transcriptase-polymerase chain reaction and islet cell carcinoma: not antagonist, but complementary tools (letter; comment). J Clin Oncol 16: 806–807
Blobel GA, Gould VE, Moll R, Lee I, Huszar M, Geiger B and Franke WW (1985) Coexpression of neuroendocrine markers and epithelial cytoskeletal proteins in bronchopulmonary neuroendocrine neoplasms. Lab Invest 52: 39–51
Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632–260
Braun S and Pantel K (1998) Prognostic significance of micrometastatic bone marrow involvement. Breast Cancer Res Treat 52: 201–216
Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr., Anderson WF and Ihle JN (1993) Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341: 85–86
Broers JL, Carney DN, Klein Rot M, Schaart G, Lane EB, Vooijs GP and Ramaekers FC (1986) Intermediate filament proteins in classic and variant types of small cell lung carcinoma cell lines: a biochemical and immunochemical analysis using a panel of monoclonal and polyclonal antibodies. J Cell Sci 83: 37–60
Broers JL, Rot MK, Oostendorp T, Huysmans A, Wagenaar SS, Wiersma-van Tilburg AJ, Vooijs GP and Ramaekers FC (1987) Immunocytochemical detection of human lung cancer heterogeneity using antibodies to epithelial, neuronal, and neuroendocrine antigens. Cancer Res 47: 3225–3234
Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R and Kanz L (1994) Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors (see comments). Blood 83: 636–640
Conover WJ (1971). In Practical nonparametric statistics, John Wiley and Sons: New York
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH and Roth MS (1994) Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol 12: 475–482
Ettinger DS, Karp JE, Abeloff MD, Burke PJ and Braine HG (1978) Intermittent high-dose cyclophosphamide chemotherapy for small cell carcinoma of the lung. Cancer Treat Rep 62: 413–424
Farha P, Spitzer G, Valdivieso M, Dicke KA, Zander A, Dhingra HM, Minnhaar G, Vellekoop L, Verma DS and Umsawasdi T et al (1983) High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 52: 1351–1355
Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE and Moscinski LC (1996) Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Oncol 14: 1868–1876
Franklin WA, Glaspy J, Pflaumer SM, Jones RB, Hami L, Martinez C, Murphy JR and Shpall EJ (1999) Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone. Blood 94: 340–347
Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F and Freeman GJ et al (1991) Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma (see comments). N Engl J Med 325: 1525–1533
Helfrich W, ten Poele R, Meersma GJ, Mulder NH, de Vries EG, de Leij L and Smit EF (1997) A quantitative reverse transcriptase polymerase chain reaction-based assay to detect carcinoma cells in peripheral blood. Br J Cancer 76: 29–35
Hirsch F, Hansen HH, Dombernowsky P and Hainau B (1977) Bone-marrow examination in the staging of small-cell anaplastic carcinoma of the lung with special reference to subtyping. An evaluation of 203 consecutive patients. Cancer 39: 2563–2567
Kim J, Kaye FJ, Henslee JG, Shively JE, Park JG, Lai SL, Linnoila RI, Mulshine JL and Gazdar AF (1992) Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers. Int J Cancer 52: 718–725
Krismann M, Todt B, Schroder J, Gareis D, Muller KM, Seeber S and Schutte J (1995) Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13: 2769–2775
Krüger WH, Jung R, Hennings S, Kröger N and Zander A (1998) Cytokine-influence on specificity of cytokeratin-19 RT-PCR for cancer cell detection. Bone Marrow Transplant 21: S185
Lambrechts AC, van’t Veer LJ and Rodenhuis S (1998) The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol 9: 1269–1276
Lassalle P, Molet S, Janin A, Heyden JV, Tavernier J, Fiers W, Devos R and Tonnel AB (1996) ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem 271: 20458–20464
Leyvraz S, Perey L, Rosti G, Lange A, Pampallona S, Peters R, Humblet Y, Bosquee L, Pasini F and Marangolo M (1999) Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation. J Clin Oncol 17: 3531–3539
Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P, Ferrari MG, Savarino M, Frassoldati A and Torelli G (1996) Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7: 619–624
Moss TJ, Sanders DG, Lasky LC and Bostrom B (1990) Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 76: 1879–1883
Muggia FM, Krezoski SK and Hansen HH (1974) Cell kinetic studies in patients with small cell carcinoma of the lung. Cancer 34: 1683–1690
Pasini F, Pelosi G, Mostacci R, Santo A, Masotti A, Spagnolli P, Recaldin E and Cetto GL (1995) Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations. Ann Oncol 6: 86–88
Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE and Kennedy MJ (1996) Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor. J Clin Oncol 14: 2569–2575
Pettengell R, Woll PJ, Thatcher N, Dexter TM and Testa NG (1995) Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 13: 148–156
Rill DR, Santana VM, Roberts WM, Nilson T, Bowman LC, Krance RA, Heslop HE, Moen RC, Ihle JN and Brenner MK (1994) Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84: 380–383
Ross AA (1998) Minimal residual disease in solid tumor malignancies: a review. J Hematother 7: 9–18
Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE and Sweet D et al (1993) Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques (see comments). Blood 82: 2605–2610
Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y and Coombes RC (1997) The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854–861
Shy SW, Lee WH, Chou MC, Lai YS and Tu YC (1990) Small cell lung carcinoma: clinicopathological, immunohistochemical, and ultrastructural study. J Surg Oncol 45: 146–161
Souhami RL, Finn G, Gregory WM, Birkhead BG, Buckman R, Edwards D, Goldstone AH, Harper PG, Spiro SG and Tobias JS et al (1985) High-dose cyclophosphamide in small-cell carcinoma of the lung. J Clin Oncol 3: 958–963
Stahel RA, Mabry M, Skarin AT, Speak J and Bernal SD (1985) Detection of bone marrow metastasis in small-cell lung cancer by monoclonal antibody. J Clin Oncol 3: 455–461
Stahel RA, Ginsberg R, Havermann K, Hirsch FR, Ihde DC, Jassem J, Karrer K, Maurer LM, Osterlind K and P VH (1989) Staging and prognostic factors in small cell lung: a consensus report. Lung Cancer 5: 119–126
Steward WP, von Pawel J, Gatzemeier U, Woll P, Thatcher N, Koschel G, Clancy L, Verweij J, de Wit R, Pfeifer W, Fennelly J, von Eiff M and Frisch J (1998) Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol 16: 642–650
Thatcher N, Girling DJ, Hopwood P, Sambrook RJ, Qian W and Stephens RJ (2000) Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party. J Clin Oncol 18: 395–404
Weiss RB (1978) Small-cell carcinoma of the lung: therapeutic management. Ann Intern Med 88: 522–531
Weiss W, Boucot KR and Cooper DA (1970) The histopathology of bronchogenic carcinoma and its relation to growth rate, metastasis, and prognosis. Cancer 26: 965–970
Woll PJ, Hodgetts J, Lomax L, Bildet F, Cour-Chabernaud V and Thatcher N (1995) Can cytotoxic dose-intensity by increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol 13: 652–659
Yan P, Bosman FT and Benhattar J (1998) Tissue quality is an important determinant of telomerase activity as measured by TRAP assay. Biotechniques 25: 660–662
Zar JH (1974). In Biostatistical Analysis, Prentice-Hall: Englewood Cliffs, NJ 127
Zhong XY, Kaul S, Diel I, Eichler A and Bastert G (1999) Analysis of sensitivity and specificity of cytokeratin 19 reverse transcriptase/polymerase chain reaction for detection of occult breast cancer in bone marrow and leukapheresis products. J Cancer Res Clin Oncol 125: 286–291
Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Riethmuller G and Pantel K (1997) Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow [see comments]. J Clin Oncol 15: 2701–2708
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Perey, L., Benhattar, J., Peters, R. et al. High tumour contamination of leukaphereses in patients with small cell carcinoma of the lung: a comparison of immunocytochemistry and RT-PCR. Br J Cancer 85, 1713–1721 (2001). https://doi.org/10.1054/bjoc.2001.2177
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.2177
Keywords
This article is cited by
-
Endocan as a prognostic biomarker of triple-negative breast cancer
Breast Cancer Research and Treatment (2017)
-
Biological and clinical implications of endocan in gastric cancer
Tumor Biology (2014)
-
Induction of cell differentiation and promotion of endocan gene expression in stomach cancer by melatonin
Molecular Biology Reports (2012)
-
ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma
Amino Acids (2011)